‘Changing the whole game of drug discovery’: legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO

Roger Perlmutter needs no introduction to anyone remotely involved in biopharma. As the R&D chief first at Amgen and then Merck, he’s built a stellar reputation and a prolific career steering new drugs toward the market for everything from cancer to infectious diseases. But for years, he’s also held a…

...

Click to view original post